Liberale, Luca
Ministrini, Stefano
Arnold, Markus
Puspitasari, Yustina M.
Pokorny, Thomas
Beer, Georgia
Scherrer, Natalie
Schweizer, Juliane
Christ-Crain, Mirjam
Montecucco, Fabrizio
Camici, Giovanni G.
Katan Kahles, Mira
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030, 182267)
Schweizerische Herzstiftung
Else von Sick Stiftung
Foundation for Cardiovascular Research
Article History
Received: 20 April 2022
Accepted: 26 October 2022
First Online: 28 November 2022
Competing interests
: Dr. Liberale and Prof. Camici are coinventors on the International Patent WO/2020/226993 filed in April 2020; the patent relates to the use of antibodies which specifically bind interleukin-1a to reduce various sequelae of ischemia–reperfusion injury to the central nervous system. Prof. Camici is a consultant to Sovida solutions limited. Dr Liberale has received financial support from the Swiss Heart Foundation and the Novartis Foundation for Medical-Biological Research. Dr. Arnold has received speaker honoraria outside of this work from Daichi-Sankyo. Dr. Arnold reports grants from the Kurt und Senta Hermann Stiftung during the conduct of the study. Dr. Arnold received personal fees from Bayer, BMS, Covidien, Medtronic, Amgen, Daiichi Sankyo, Nestle Health Science, and Boehringer Ingelheim, outside the submitted work. Prof. Christ-Crain received speaker honoraria from Thermo Fisher AG. Prof. Montecucco has received financial support from the “Rete Cardiologica” of Italian Ministry of Health (#2754291). Prof. Camici is the recipient of a Sheikh Khalifa’s Foundation Assistant Professorship at the Faculty of Medicine, University of Zurich. Prof. Katan Kahles reports grants from Spital-Pool of the University Hospital of Zurich and EMDO Foundation during the conduction of the study. Prof. Katan Kahles received non-financial support from Spital-Pool of the University Hospital of Zurich and ROCHE, outside the submitted work. None of the remaining Authors has potential conflict of interest to disclose. All other Authors declare no conflict of interest.